Strength Training Following Gastric Bypass for Obesity - Tabular View

Tracking Information

First Received Date ^ICMJE

July 16, 2003

Last Updated Date

December 27, 2007

Start Date ^ICMJE

March 2003

Primary Completion Date

December 2006 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Original Primary Outcome Measures ^ICMJE

Change History

Complete list of historical versions of study NCT00065013 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Strength Training Following Gastric Bypass for Obesity

Official Title ^ICMJE

Strength Training Following Gastric Bypass for Obesity

Brief Summary

We will assess whether undesirable loss of lean tissue following gastric bypass surgery for obesity can be minimized by protein supplementation and exercise training.

Detailed Description

Study Phase

Phase II

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study

Condition ^ICMJE

Obesity

Intervention ^ICMJE

Behavioral: strength training

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

December 2006

Primary Completion Date

December 2006 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

clinically severe obesity
candidate for bypass surgery
new york city local address
willing to visit hospital weekly

Gender

Female

Ages

18 Years to 52 Years

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Administrative Information

NCT ID ^ICMJE

NCT00065013

Responsible Party

Allan Geliebter, St. Luke's-Roosevelt Hospital

Study ID Numbers ^ICMJE

STGASB, R03DK061519

Study Sponsor ^ICMJE

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

Allan Geliebter, PhD

St. Luke's-Roosevelt Hospital Center

Information Provided By

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Verification Date

December 2007

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP